Skip to main content

Opko Health, Inc.

OPK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000944809

No open-market purchases or sales by Opko Health, Inc. insiders were filed in the last 90 days; 222 institutions reported holding it in 13F filings for Q2 2026, worth $303.4M in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Opko Health, Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of OPK: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders225218−7
Shares167.2M169.9M+2.69M (+1.6%)
Value$267.6M$256.6M−$11.0M (−4.1%)

New holders (25)

Institutions that held Opko Health, Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to OPK in Q4 2023
InstitutionSharesValue% of portfolio
Portolan Capital Management, LLC1,661,766$2.51M0.22%
Weiss Multi-Strategy Advisers LLC700,000$1.06M0.03%
Alps Advisors Inc536,481$810.1K0.01%
Group One Trading, L.P.308,615$466.0K0.01%
First Trust Advisors LP305,731$461.7K0.00%
POM Investment Strategies, LLC158,053$238.7K0.22%
Simplex Trading, LLC148,360$224.0K0.01%
Parallax Volatility Advisers, L.P.134,280$202.8K0.01%
Deerfield Management Company, L.P. (Series C)80,348$121.3K0.00%
RSM US Wealth Management LLC70,000$105.7K0.00%
HSBC Holdings PLC29,255$44.2K0.00%
Northstar Group, Inc.27,785$42.0K0.01%
Susquehanna International Group Ltd.25,284$38.2K0.01%
IPG Investment Advisors LLC20,000$30.2K0.01%
Apollon Wealth Management, LLC12,910$19.5K0.00%
Two Sigma Securities, LLC11,617$17.5K0.00%
Fairfield, Bush & Co.7,245$10.9K0.01%
FSA Wealth Management LLC3,950$6.00K0.00%
Wolverine Asset Management LLC2,023$3.05K0.00%
Baystate Wealth Management LLC1,000$1.51K0.00%
EverSource Wealth Advisors, LLC666$1.01K0.00%
Wetzel Investment Advisors, Inc.400$1.00K0.00%
Northwestern Mutual Wealth Management Co401$6060.00%
Rothschild Investment LLC200$3020.00%
GWM Advisors LLC2$30.00%

Sold out (32)

Institutions that held Opko Health, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.